THEORETICAL STUDY OF ANTIFOLATES AS INHIBITORS OF THYMIDYLATE SYNTHASE
抗叶酸药作为胸苷酸合酶抑制剂的理论研究
基本信息
- 批准号:6347966
- 负责人:
- 金额:$ 4.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-07-01 至 2001-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Thymidylate Synthase (TS) catalyzes the conversion of dUMP and
5,10-CH2-H4folate into dTMP. It is the only known path for dTMP
synthesis. dTMP synthesis is believed to be one of the rate limiting
steps in DNA replication. The inhibitor of this enzyme can be used to
block dTMP synthesis and can be of possible chemotherapeutic use for
cancers. We performed Free Energy Perturbation (FEP) calculations on
selected molecules with different combinations of substitutions of
inhibitors. The calculation results agree with experimental values
for selected inhibitors that lack glutamate residues. Most of these
compounds have the same
N-((3,4-dihydro-2-methyl-6-quinazolinyl)methyl)-N-prop-2-ynylaniline
structure. The aniline was substituted with simple lipophilic
substituents at different positions. A set of Pictorial
Representation of Free Energy Change (PROFEC) calculations was also
performed. We found that fluorine-substitution at the R5 and R6
positions enhances binding. The most encouraging result is that one
compound shows about 6 Kcal/mole binding enhancement. It suggested
that R5 or R6 substitution could be a new direction for the design of
TS inhibitors. The Computer Graphics Laboratory is crucial in
designing the inhibitors and viewing the PROFEC results, especially
the 3D ability.
胸苷合成酶(TS)催化DUMP和
5,10-CH2-H4叶酸加入DTMP。这是唯一已知的DTMP路径
综合。DTMP的合成被认为是速度限制之一
DNA复制的步骤。这种酶的抑制剂可以用来
阻断DTMP的合成并可能用于化疗
癌症。我们进行了自由能微扰(FEP)计算
具有不同取代基组合的选定分子
抑制剂。计算结果与实验值吻合较好。
用于缺乏谷氨酸残留物的选定抑制剂。其中大多数都是
化合物具有相同的
N-((3,4-dihydro-2-methyl-6-quinazolinyl)methyl)-N-prop-2-ynylaniline
结构。用简单的亲脂性取代了苯胺。
不同位置的取代基。一套画报
自由能变化(PROFEC)计算的表示也是
已执行。我们发现R5和R6上的氟取代
位置增强了约束性。最鼓舞人心的结果是
化合物的结合能力提高了约6Kcal/摩尔。它建议
R5或R6的替代可能是设计的一个新方向
TS抑制剂。计算机图形学实验室在
设计抑制剂和查看PROFEC结果,尤其是
3D能力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TAI-SUNG LEE其他文献
TAI-SUNG LEE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TAI-SUNG LEE', 18)}}的其他基金
A next-generation extendable simulation environment for affordable, accurate, and efficient free energy simulations
下一代可扩展模拟环境,可实现经济、准确且高效的自由能源模拟
- 批准号:
10638121 - 财政年份:2023
- 资助金额:
$ 4.13万 - 项目类别:
AN ALTERNATIVE EXPLANATION FOR THE CATALYTIC PROFICIENCY OF ODCASE
ODCASE 催化能力的另一种解释
- 批准号:
6976114 - 财政年份:2004
- 资助金额:
$ 4.13万 - 项目类别:
THEORETICAL STUDY OF ANTIFOLATES AS INHIBITORS OF THYMIDYLATE SYNTHASE
抗叶酸药作为胸苷酸合酶抑制剂的理论研究
- 批准号:
6456804 - 财政年份:2001
- 资助金额:
$ 4.13万 - 项目类别:
DEVELOPMENT AND APPLICATION OF A NEW QM/MM METHOD
新QM/MM方法的开发和应用
- 批准号:
2900482 - 财政年份:1999
- 资助金额:
$ 4.13万 - 项目类别:
THEORETICAL STUDY OF ANTIFOLATES AS INHIBITORS OF THYMIDYLATE SYNTHASE
抗叶酸药作为胸苷酸合酶抑制剂的理论研究
- 批准号:
6220336 - 财政年份:1999
- 资助金额:
$ 4.13万 - 项目类别:
DEVELOPMENT AND APPLICATION OF A NEW QM/MM METHOD
新QM/MM方法的开发和应用
- 批准号:
2637506 - 财政年份:1998
- 资助金额:
$ 4.13万 - 项目类别:
相似海外基金
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10448926 - 财政年份:2021
- 资助金额:
$ 4.13万 - 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10491861 - 财政年份:2021
- 资助金额:
$ 4.13万 - 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10675535 - 财政年份:2021
- 资助金额:
$ 4.13万 - 项目类别:
EPSRC Centre for Doctoral Training in Bioprocess Engineering Leadership (Complex Biological Products Manufacture)
EPSRC 生物过程工程领导力博士培训中心(复杂生物制品制造)
- 批准号:
EP/S021868/1 - 财政年份:2019
- 资助金额:
$ 4.13万 - 项目类别:
Training Grant
Exploring interactions and benefits of novel microbial biological products in blueberry propagation
探索新型微生物生物制品在蓝莓繁殖中的相互作用和益处
- 批准号:
529840-2018 - 财政年份:2018
- 资助金额:
$ 4.13万 - 项目类别:
Applied Research and Development Grants - Level 1
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
- 批准号:
1403724 - 财政年份:2014
- 资助金额:
$ 4.13万 - 项目类别:
Standard Grant
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
- 批准号:
1403697 - 财政年份:2014
- 资助金额:
$ 4.13万 - 项目类别:
Standard Grant
Formulation and delivery approaches for water soluble biological products delivered through the skin focussing on L-Ascorbic Acid.
通过皮肤输送的水溶性生物产品的配方和输送方法,重点是 L-抗坏血酸。
- 批准号:
131690 - 财政年份:2014
- 资助金额:
$ 4.13万 - 项目类别:
Feasibility Studies
Formulation and stability of biological products for skin delivery focussing on Retinol.
以视黄醇为重点的皮肤输送生物制品的配方和稳定性。
- 批准号:
131338 - 财政年份:2013
- 资助金额:
$ 4.13万 - 项目类别:
Feasibility Studies
Demonstrate the effectiveness of antimicrobial protection of new types of Biological Products
展示新型生物制品抗菌保护的有效性
- 批准号:
429734-2011 - 财政年份:2012
- 资助金额:
$ 4.13万 - 项目类别:
Experience Awards (previously Industrial Undergraduate Student Research Awards)